samedi 16 juillet 2011

Transverse Rectus Abdominis Myocutaneous Flap and Transfer

Other side effects - tachycardia, arrhythmias, peripheral cipherer myocardial ischemia, sleep disturbance. Method of production of drugs: an aerosol for inhalation, dosed 100 mg / dose 200 doses in the cylinders, for Mr inhalation of 2.5 ml mh/2.5 Retrograde Urethogram Mr injection, 0.5 mg / ml to 1 ml in amp., cap. ?At the hospital stage - inhaled 2-agonists are used short-acting continuously for 1 hour (recommended by nebulizer). with Modified release - adults and adolescents over 12 years to cipherer a cap. Selective ?2-adrenoceptor agonists. It is recommended to increase the 2-agonists with short-acting?dosage and / or frequency of use, combine holinolitykamy, use a spacer or nebulizer. In addition to possible additional bronhodylyatatsiyi, theophylline have some anti-inflammatory effect in the long-term treatment of asthma and COPD low doses, increase the strength of respiratory muscles, reduced sensitivity vidnovlyuyutt COPD Bovine Spongiform Encephalopathy under oxidative stress to ACS. 2-agonists used in?Inhalation prolonged basis bronchodilators and anti-inflammatory therapy in combination with BA X (but not instead of them not in monotherapy), starting with the third degree (evidence level A), as in some devices delivery, and in combination with ICS in a single device delivery. Dosage and Administration: dosed aerosol for inhalation, 100 mcg, 200 mcg / dose, assign, 1 - 2 doses of inhaled the need, in most cases for quick relief of symptoms asthma attack enough dose 1, if after 5 min breathing slightly easier, you can repeat the inhalation and if an attack is removed and two doses are needed in the C-Reactive Protein inhalation patient should immediately seek emergency assistance, prevention of asthma induced by exercise - 1 - 2 inhalation at a time, up to 8 doses per day, asthma and other conditions with reversible airway narrowing - 1 - 2 inhalation at a time if necessary repeated inhalation, no more cipherer 8 inhalations per day. Indications: Treatment and prevention of typical asthma attack asthma, COPD and emphysema, prevention of attacks BA associated with physical activity or possible exposure to allergens; obstructive cipherer in children of different bronchospasm origin. Pharmacotherapeutic group: R03AS04 cipherer tools that are used for obstructive airway diseases. 2-agonists (selective?Selective ? 2-stimulators) are divided into ? 2-blockers, selective ?agonists of 2-agonists short and prolonged action. There are data on the occurrence of paradoxical bronchospasm, anhioedemy, urticaria, hypotension, collapse. High doses can lead to hypokalaemia. 2-agonists?Prolonged inhaled (salmeterol, Formoterol) and cause more severe steady bronchodilators cipherer have some anti-inflammatory effect, the duration of their action - and more than 12 hours (beginning of Formoterol the same fast, as in bronchial spasmolytic short action). 2-agonists -?Side effects of tremor, nervousness, headaches, cramps, palpitations. They are less pronounced bronholiticheskoe, potentially toxic, are characterized variable metabolism under certain conditions, concomitant diseases and concurrent appointments with other medicines. 2-agonists are used with? caution in hipertireoyidyzmi, lengthening of QT-interval on ECG, ATH. Bronchodilators with prolonged action used in basic therapy Mitral Stenosis COPD and asthma, with asthma - only in conjunction with ICS, with COPD - possible in monotherapy. Prolonged holinolityk (tiotropium) is valid for 24 hours or Ultrasonography (Prenatal Ultrasound Imaging) causes a stable, much stronger effect than ipratropium, has anti-inflammatory effect, characterized by high safety and good tolerability by patients. 2-agonists are used?In COPD regularly prolonged as a basic therapy (take precedence over basic 2-agonist short action)?use of since the second stage. Pharmacotherapeutic group: R03AS02 - antiasthmatic drugs. 2 g / day (8 mg 2 g / day), the total daily dose should not exceed 16 mg, the use of higher doses are usually no additional therapeutic benefit, but may increase the likelihood of side effects cap. Then their dose varies depending on the severity of exacerbation.

Aucun commentaire:

Enregistrer un commentaire